SNX13 and breast carcinoma: Interestingly, SNX13 was shown to be downregulated in all breast cancer subtypes, but particularly in the triple-negative subtype (Additional file 1: Fig S10c), which may result in worse prognosis for all subtypes of- breast cancer because of a higher rate of triple negative breast cancer subtype (Additional file 1: Fig S10d).